Literature DB >> 10484795

Genetic analysis of the G4.5 gene in families with suspected Barth syndrome.

A M Cantlay1, K Shokrollahi, J T Allen, P W Lunt, R A Newbury-Ecob, C G Steward.   

Abstract

Mutations have recently been identified in the G4.5 gene (Xq28), encoding the tafazzin protein, in patients with Barth syndrome. We performed mutational analysis in 5 families with suspected Barth syndrome. In 4 families a male child had all the cardinal features of this syndrome, and mutations of G4.5 were found in each case. A mutation was also found in a fifth family with an extensive history of early infant death from heart disease. The recognition of 5 unrelated families in 1 hospital during a 7-year period suggests that this disease may be underdiagnosed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484795     DOI: 10.1016/s0022-3476(99)70126-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  25 in total

1.  Normal pituitary function in a Japanese patient with Barth syndrome.

Authors:  Yuriko Katsushima; Ikuma Fujiwara; Osamu Sakamoto; Toshihiro Ohura; Shigeaki Miyabayashi; Akira Ohnuma; Seiji Yamaguchi; Kazuie Iinuma
Journal:  Eur J Pediatr       Date:  2002-01       Impact factor: 3.183

2.  Barth syndrome diagnosed in the subclinical stage of heart failure based on the presence of lipid storage myopathy and isolated noncompaction of the ventricular myocardium.

Authors:  Atsuhito Takeda; Akira Sudo; Masafumi Yamada; Hirokuni Yamazawa; Gaku Izumi; Ichizo Nishino; Tadashi Ariga
Journal:  Eur J Pediatr       Date:  2011-09-20       Impact factor: 3.183

Review 3.  Acute metabolic decompensation and sudden death in Barth syndrome: report of a family and a literature review.

Authors:  Ting-Yu Yen; Wuh-Liang Hwu; Yin-Hsiu Chien; Mei-Hwan Wu; Ming-Tai Lin; Lon-Yen Tsao; Wu-Shiun Hsieh; Ni-Chung Lee
Journal:  Eur J Pediatr       Date:  2007-09-11       Impact factor: 3.183

Review 4.  Eponym: Barth syndrome.

Authors:  Atsuhito Takeda; Akira Sudo; Masafumi Yamada; Hirokuni Yamazawa; Gaku Izumi; Ichizo Nishino; Tadashi Ariga
Journal:  Eur J Pediatr       Date:  2011-09-23       Impact factor: 3.183

Review 5.  TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome.

Authors:  Anders O Garlid; Calvin T Schaffer; Jaewoo Kim; Hirsh Bhatt; Vladimir Guevara-Gonzalez; Peipei Ping
Journal:  Gene       Date:  2019-10-21       Impact factor: 3.688

6.  Barth syndrome is associated with a cognitive phenotype.

Authors:  Michèle M M Mazzocco; Anne E Henry; Richard I Kelly
Journal:  J Dev Behav Pediatr       Date:  2007-02       Impact factor: 2.225

Review 7.  Inborn errors of metabolism underlying primary immunodeficiencies.

Authors:  Nima Parvaneh; Pierre Quartier; Parastoo Rostami; Jean-Laurent Casanova; Pascale de Lonlay
Journal:  J Clin Immunol       Date:  2014-08-01       Impact factor: 8.317

8.  Clinical Characteristics and Outcomes of Cardiomyopathy in Barth Syndrome: The UK Experience.

Authors:  Sok-Leng Kang; Jonathan Forsey; Declan Dudley; Colin G Steward; Beverly Tsai-Goodman
Journal:  Pediatr Cardiol       Date:  2015-09-04       Impact factor: 1.655

9.  A Novel Exonic Splicing Mutation in the TAZ (G4.5) Gene in a Case with Atypical Barth Syndrome.

Authors:  Yuxin Fan; Jon Steller; Iris L Gonzalez; Wim Kulik; Michelle Fox; Richard Chang; Brandy A Westerfield; Anjan S Batra; Raymond Yu Jeang Wang; Natalie M Gallant; Liana S Pena; Hu Wang; Taosheng Huang; Sunita Bhuta; Daniel J Penny; Edward R McCabe; Virginia E Kimonis
Journal:  JIMD Rep       Date:  2013-04-19

10.  Diagnosis of Barth syndrome using a novel LC-MS/MS method for leukocyte cardiolipin analysis.

Authors:  Ann Bowron; Robert Frost; Vicki E C Powers; Paul H Thomas; Simon J R Heales; Colin G Steward
Journal:  J Inherit Metab Dis       Date:  2012-10-30       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.